Your browser is no longer supported. Please, upgrade your browser.
XBIT XBiotech Inc. daily Stock Chart
XBiotech Inc.
Index- P/E1.81 EPS (ttm)9.40 Insider Own50.60% Shs Outstand36.17M Perf Week9.60%
Market Cap506.39M Forward P/E- EPS next Y- Insider Trans-9.94% Shs Float14.01M Perf Month11.98%
Income674.50M PEG- EPS next Q- Inst Own16.50% Short Float15.42% Perf Quarter19.96%
Sales12.70M P/S39.87 EPS this Y- Inst Trans2.72% Short Ratio12.18 Perf Half Y2.90%
Book/sh9.60 P/B1.77 EPS next Y- ROA205.40% Target Price18.00 Perf Year120.05%
Cash/sh8.11 P/C2.10 EPS next 5Y- ROE218.10% 52W Range7.27 - 26.40 Perf YTD-8.87%
Dividend- P/FCF- EPS past 5Y87.30% ROI- 52W High-35.57% Beta1.49
Dividend %- Quick Ratio25.20 Sales past 5Y- Gross Margin23.70% 52W Low133.98% ATR0.95
Employees63 Current Ratio25.20 Sales Q/Q- Oper. Margin- RSI (14)62.33 Volatility6.52% 6.51%
OptionableYes Debt/Eq0.00 EPS Q/Q99.80% Profit Margin- Rel Volume0.55 Prev Close17.01
ShortableYes LT Debt/Eq0.00 Earnings- Payout0.00% Avg Volume177.41K Price17.01
Recom2.00 SMA208.36% SMA5014.11% SMA20013.01% Volume0 Change0.00%
Jun-14-19Initiated Piper Jaffray Overweight $13
Apr-21-17Downgrade Noble Financial Buy → Hold $13
Jun-28-16Reiterated Noble Financial Buy $24 → $30
Jul-29-20 02:32PM  
Jul-22-20 09:20AM  
Jul-14-20 09:25AM  
Jun-22-20 02:17PM  
Jun-09-20 02:09PM  
May-01-20 09:25AM  
Apr-17-20 08:45PM  
Apr-14-20 09:15AM  
Apr-03-20 04:53PM  
Feb-19-20 08:15AM  
Feb-13-20 01:24PM  
Feb-10-20 03:59PM  
Jan-15-20 08:22AM  
Jan-14-20 08:30AM  
Dec-30-19 04:05PM  
Dec-20-19 02:53PM  
Dec-17-19 08:15AM  
Dec-10-19 07:14AM  
Dec-07-19 03:05AM  
Nov-19-19 08:55AM  
Nov-12-19 08:45AM  
Oct-23-19 08:15AM  
Oct-10-19 02:57PM  
Oct-02-19 08:59AM  
Sep-27-19 08:15AM  
Sep-20-19 08:15AM  
Jul-16-19 01:15PM  
Jul-11-19 08:30AM  
Jul-10-19 08:00AM  
Jul-09-19 08:00AM  
Jun-26-19 08:30AM  
Jun-25-19 08:45AM  
Jun-11-19 08:00AM  
Jun-04-19 04:01PM  
May-31-19 08:47AM  
May-30-19 04:32PM  
May-23-19 08:20AM  
May-13-19 09:27AM  
May-02-19 08:15AM  
Apr-29-19 07:54AM  
Mar-04-19 01:44PM  
Mar-01-19 12:54PM  
Feb-07-19 11:19AM  
Feb-06-19 02:20PM  
Jan-29-19 08:15AM  
Jan-28-19 11:28AM  
Jan-23-19 08:30AM  
Dec-13-18 08:00AM  
Dec-12-18 08:30AM  
Dec-03-18 08:15AM  
Nov-23-18 07:35AM  
Oct-31-18 04:05PM  
Oct-26-18 08:15AM  
Oct-24-18 10:35AM  
Oct-05-18 08:00AM  
Sep-26-18 08:00AM  
Sep-24-18 08:30AM  
Sep-20-18 08:00AM  
Sep-13-18 08:00AM  
Sep-12-18 08:00AM  
Aug-27-18 08:00AM  
Aug-10-18 08:00AM  
Jul-10-18 08:01AM  
May-22-18 08:01AM  
Apr-16-18 08:01AM  
Apr-02-18 08:01AM  
Jan-29-18 07:30AM  
Jan-26-18 08:01AM  
Jan-25-18 08:01AM  
Jan-22-18 07:20AM  
Jan-19-18 08:01AM  
Dec-11-17 11:18AM  
Dec-04-17 04:15PM  
Nov-17-17 03:39PM  
Nov-16-17 06:08PM  
Nov-14-17 07:31AM  
Nov-08-17 02:30PM  
Nov-03-17 12:18PM  
Nov-02-17 04:42PM  
Oct-26-17 02:54PM  
Oct-19-17 11:57AM  
Oct-18-17 10:41AM  
Oct-03-17 08:00AM  
Sep-21-17 08:01AM  
Sep-20-17 08:00AM  
Sep-18-17 06:16PM  
Sep-07-17 08:00AM  
Jul-11-17 12:25PM  
Jun-22-17 04:37PM  
Jun-21-17 03:43PM  
Jun-13-17 08:00AM  
Jun-12-17 09:22AM  
Jun-09-17 03:32PM  
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of antibody therapies for treating oncology, inflammatory conditions, and infectious diseases. Its product candidates include 514G3, an anti-infective antibody that is in Phase II clinical trial for the treatment of Staphylococcus Aureus infections; and other anti-infectious disease antibodies, which are in pre-clinical development to treat Clostridium Difficile, influenza, Ebola, and Herpes Varicella Zoster (Chickenpox). XBiotech Inc. has a collaboration with BioBridge Global for the development of potential COVID 19 treatment based on natural antibodies from recovered patients. The company was founded in 2005 and is headquartered in Austin, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BAY STREET FINANCIAL S.A.10% OwnerFeb 19Sale6.381,662,61610,607,4903,337,384Mar 25 10:09 AM
MCKENZIE W THORPEDirectorJan 06Option Exercise3.75123,000461,2503,706,600Jan 09 04:19 PM
MCKENZIE W THORPEDirectorNov 29Option Exercise3.75185,000693,7503,583,600Dec 04 03:29 PM
MCKENZIE W THORPEDirectorSep 06Sale3.697,15926,3973,880,421Sep 06 04:35 PM